Transferable quinolone resistance in vibrio cholerae

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 799-803

  Kim, Hong Bin ^a,b,c   Wang, Minghua ^c,d   Ahmed, Sabeena ^e   Park, Chi Hye ^c   LaRocque, Regina C ^c   Faruque, Abu S G ^e   Salam, Mohammed A ^e   Khan, Wasif A ^e   Qadri, Firdausi ^e   Calderwood, Stephen B ^c   Jacoby, George A ^f   Hooper, David C ^c  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d FUDAN UNIVERSITY   (China)

^e INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^f LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE IV; DOXYCYCLINE; PENTAPEPTIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; CHOLERA; CONTROLLED STUDY; CORRELATIONAL STUDY; ESCHERICHIA COLI; GENE MUTATION; GYRA GENE; LABORATORY; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; PRIORITY JOURNAL; QNR GENE; QNRVC3 GENE; TYPHOID FEVER; VIBRIO CHOLERAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHROMOSOMES, BACTERIAL; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; QUINOLONES; VIBRIO CHOLERAE;

EID: 75749092947     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01045-09     Document Type: Article

References (29)

1. Baranwal, S., K. Dey, T. Ramamurthy, G. B. Nair, and M. Kundu. 2002. Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob. Agents Chemother. 46:2676-2678.
2. Barker, A., C. A. Clark, and P. A. Manning. 1994. Identification of VCR, a repeated sequence associated with a locus encoding a hemagglutinin in Vibrio cholerae O1. J. Bacteriol. 176:5450-5458.
3. Biskri, L., M. Bouvier, A. M. Guerout, S. Boisnard, and D. Mazel. 2005. Comparative study of class 1 integron and Vibrio cholerae superintegron integrase activities. J. Bacteriol. 187:1740-1750.
4. Burrus, V., J. Marrero, and M. K. Waldor. 2006. The current ICE age: biology and evolution of SXT-related integrating conjugative elements. Plasmid 55:173-183.
5. Cattoir, V., L. Poirel, D. Mazel, C. J. Soussy, and P. Nordmann. 2007. Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob. Agents Chemother. 51:2650-2651.
6. CLSI. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Crump, J. A., K. Kretsinger, K. Gay, R. Hoekstra, D. J. Vugia, S. Hurd, S. D. Segler, M. Megginson, L. Luedeman, B. Shiferaw, S. S. Hanna, K. W. Joyce, E. D. Mintz, F. J. Angulo, and the Emerging Infections Program FoodNet and NARMS Working Groups. 2008. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States FoodNet multicenter retrospective cohort study. Antimicrob. Agents Chemother. 52:1278-1284.
8. Faruque, S. M., M. J. Islam, Q. S. Ahmad, K. Biswas, A. S. Faruque, G. B. Nair, R. B. Sack, D. A. Sack, and J. J. Mekalanos. 2006. An improved technique for isolation of environmental Vibrio cholerae with epidemic potential: monitoring the emergence of a multiple-antibiotic-resistant epidemic strain in Bangladesh. J. Infect. Dis. 193:1029-1036.
9. Fonseca, É . L., F. dos Santos Freitas, V. V. Vieira, and A. C. P. Vicente. 2008. New qnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1. Emerg. Infect. Dis. 14:1129-1131.
10. Hochhut, B., Y. Lotfi, D. Mazel, S. M. Faruque, R. Woodgate, and M. K. Waldor. 2001. Molecular analysis of antibiotic resistance gene clusters in Vibrio cholerae O139 and O1SXT constins. Antimicrob. Agents Chemother. 45:2991-3000.
11. Hooper, D. C. 2003. Mechanisms of quinolone resistance, p. 41-67. In D. C. Hooper and E. Rubinstein (ed.), Quinolone antimicrobial agents, 3rd ed. ASM Press, Washington, DC.
12. +-coupled multidrug efflux pump, from Vibrio cholerae non-O1. Microbiol. Immunol. 47:419-427.
13. +-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium. FEMS Microbiol. Lett. 203:235-239.
14. Huda, N., E. W. Lee, J. Chen, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in non-O1 Vibrio cholerae. Antimicrob. Agents Chemother. 47:2413-2417.
15. Khan, W. A., M. L. Bennish, C. Seas, E. H. Khan, A. Ronan, U. Dhar, W. Busch, and M. A. Salam. 1996. Randomised controlled comparison of singledose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139. Lancet 348:296-300.
16. Kim, H. B., C. H. Park, C. J. Kim, E.-C. Kim, G. A. Jacoby, and D. C. Hooper. 2009. Prevalence of plasmid-mediated quinolone resistance determinants over a nine-year period. Antimicrob. Agents Chemother. 53:639-645.
17. Mazel, D. 2006. Integrons: agents of bacterial evolution. Nat. Rev. Microbiol. 4:608-620.
18. Poirel, L., A. Liard, J. M. Rodriguez-Martinez, and P. Nordmann. 2005. Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants. J. Antimicrob. Chemother. 56:1118-1121.
19. Rowe-Magnus, D. A., A. M. Guerout, P. Ploncard, B. Dychinco, J. Davies, and D. Mazel. 2001. The evolutionary history of chromosomal super-integrons provides an ancestry for multiresistant integrons. Proc. Natl. Acad. Sci. U. S. A. 98:652-657.
20. Saha, D., M. M. Karim, W. A. Khan, S. Ahmed, M. A. Salam, and M. L. Bennish. 2006. Single-dose azithromycin for the treatment of cholera in adults. N. Engl. J. Med. 354:2452-2462.
21. Saha, D., W. A. Khan, M. M. Karim, H. R. Chowdhury, M. A. Salam, and M. L. Bennish. 2005. Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. Lancet 366:1085-1093.
22. Saha, D., R. C. LaRocque, A. Khan, J. B. Harris, Y. A. Begum, S. M. Akramuzzaman, A. S. Faruque, E. T. Ryan, F. Qadri, and S. B. Calderwood. 2004. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J. Infect. Dis. 189:2318-2322.
23. Sánchez, M. B., A. Hernández, J. M. Rodríguez- Martínez, L. Martínez-Martínez, and J. L. Martínez. 2008. Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol. 8:148-162.
24. Stoll, B., R. Glass, M. I. Huq, M. U. Khan, J. Holt, and H. Banu. 1982. Surveillance of patients attending a diarrhoeal disease hospital in Bangladesh. Br. Med. J. 285:1185-1188.
25. Strahilevitz, J., G. A. Jacoby, D. C. Hooper, and A. Robicsek. 2009. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev. 22:664-689.
26. Tran, J. H., G. A. Jacoby, and D. C. Hooper. 2005. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 49:118-125.
27. Tran, J. H., G. A. Jacoby, and D. C. Hooper. 2005. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob. Agents Chemother. 49:3050-3052.
28. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
29. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.